Generation and application of monoclonal antibody to human pancreatic carcinoma

Hybridoma

Volumn 15, Issue 4, 1996, Pages 289-293

  Yuan, Shizhen ^a,b   Zhang, Houde ^a   Chen, Qikui ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G1; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY YPC 3; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; HYBRIDOMA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOKINE ACTIVATED KILLER CELL; MOUSE; NONHUMAN; NUDE MOUSE; PANCREAS CARCINOMA; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; XENOGRAFT;

ANIMALIA; MUS MUSCULUS;

EID: 0029781476     PISSN: 0272457X     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.1996.15.289     Document Type: Article

References (18)

1. Warshaw AL, and Castillo CF: Medical progress-pancreatic carcinoma. N Engl J Med 1992;326:455-465.
2. Casper ES: Pancreatic cancer, how can we progress? Eur J Cancer 1993:29A:171-172.
3. Yuan SZ, Ho JJ, Yuan M, and Kim YS: Human pancreatic cancer-associated antigens detected by murine monoclonal antibodies. Cancer Res 1985;45:6179-6186.
4. Mather JS, and Ellison D: Reduction-mediated technetium-99m labeling of monoclonal antibodies. J Nucl Med 1990;31:692-697.
5. Chen QK, and Yuan SZ: Radioimmunolocalization of human pancreatic carcinoma xenograft by 99mTc-labeled YPC3 monoclonal antibody. J Cancer Res Clin Oncol 1994; 120:668-671.
6. Shiloni E, Eisenthal E, Sachs D, and Rosenberg SA: Antibody-dependent cellular cytotoxicity mediated by murine lymphocytes activated in recombinant interleukin 2. J Immunol 1987;138:1992-1998.
7. Chen QK, and Yuan SZ: The anti-pancreatic cancer efficacy of LAK cells mediated by YPC3 monoclonal antibody in vitro and in vivo. Chin J Oncol 1994;16:353-355.
8. Metzgar RS, Gaillard MT, Levine SJ, Tuck FL, Bossen EH, and Borowitz MJ: Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies. Cancer Res 1982;42:601-608.
9. Grant AG, Harris PM, Heyderman B, Larkin SE, Pym B, and Jermon-Taylor J: The generation of monoclonal antibodies against human pancreatic exocrine cancer: A study of six different immunization regimes. Br J Cancer 1985;52:543-550.
10. Kajiji SM, Davceva B, and Quaranta S: Six monoclonal antibodies to human pancreatic cancer antigens. Cancer Res 1987;47:1367-1376.
11. Dippold WG, Klingel R, Bernhard H, Dienes HP, Knuth A, and Buschenfelde KHM: Secretory epithelial cell marker on gastrointestinal tumors and in human secretions defined by a monoclonal antibody. Cancer Res 1987;47:2092-2097.
12. Hnatowich DJ: Recent developments in the radiolabeling of antibodies. Semin Nucl Med 1990;20:80-91.
13. Goldenberg DM, and Larson SM: Radioimmunodetection in cancer identification. J Nucl Med 1992;33:803-814.
14. Lind P, Smola MG, Lechner P, Ratschek M, Klima G, Koltringer P, Sleindorfer P, and Eber O: The immunoscintigraphic use of Tc-99m-labeled monoclonal anti-CEA antibodies (BW 431/26) in patients with suspected primary, recurrent and metastatic breast cancer. Int J Cancer 1991;47:865-869.
15. Hertel A, Baum RP, and Lorenz M: Immunoscintigraphy using a 99mTc-labeled monoclonal anti-CEA antibody in follow-UP of colorectal cancer and others producing CEA. Br J Cancer 1990;62(suppl. X):34-36.
16. Frytak S, Creagan ET, and Brown ML: A Technetium-labeled monoclonal antibody for imaging metastatic melanoma. Am J Clin Oncol 1991;14:156-161.
17. Goldenberg DM: Imaging and therapy of gastrointestinal cancer with radiolabeled antibodies. Am J Gastroenterol 1991;86:1392-1403.
18. Tempero MA, Pour PM, Uchida E, Herlyn D, and Steplewski Z: Monoclonal antibody CO17-A and leukopheresis in immunotherapy of pancreatic cancer. Hybridoma 1986;5:S133-138.